BlossomHill Therapeutics, Inc. (BLSM) vs Tactile Systems Technology, Inc. (TCMD)

A side-by-side comparison of BlossomHill Therapeutics, Inc. and Tactile Systems Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BLSM vs TCMD

growth of $100 · dividends reinvested · last 1y
BLSM +24.6% (+24.6%/yr)TCMD -25.4% (-25.4%/yr)BLSM compounded faster over this window
80100120140160Start $100$125$75
BLSM TCMD

BLSM vs TCMD: by the numbers

  • •BLSM is the larger company ($513M vs $500M market cap).
  • •TCMD is profitable (7.10% net margin) while BLSM runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBLSMTCMD
P/E ratioN/A20.53
Forward P/EN/A19.85
P/S ratioN/A1.43
P/B ratioN/A2.23
EV / EBITDAN/A10.65
FCF yieldN/A5.34%

Profitability

MetricBLSMTCMD
Gross margin0.00%74.23%
Operating margin0.00%10.00%
Net margin0.00%7.10%
ROEN/A11.11%
ROIC-43.41%9.54%

Growth (annualized)

MetricBLSMTCMD
Revenue CAGR (5Y)N/A11.62%
FCF CAGR (5Y)N/A32.09%
Total return CAGR (5Y)N/A-11.73%

Frequently asked

Is BLSM or TCMD more profitable?
TCMD runs the higher net margin — BLSM at 0.00% versus TCMD at 7.10%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.